Status:
TERMINATED
The PPCGMS Intervention After GDM Trial
Lead Sponsor:
Woman's
Collaborating Sponsors:
DexCom, Inc.
Conditions:
Postpartum Gestational Diabetes Mellitus
Eligibility:
FEMALE
18-45 years
Phase:
NA
Brief Summary
Among women who experience glucose abnormalities during pregnancy, screening during the postpartum period offers a window of opportunity for early identification of diabetes and prediabetes. The rates...
Detailed Description
Given the damaging effect of prolonged undetected hyperglycemia, prevention and early diagnosis of T2D is cost-saving and of public health importance. Currently, screening for diabetes after childbirt...
Eligibility Criteria
Inclusion
- diagnosis of gestational diabetes during recent pregnancy (4-24 weeks)
- age 18 or older.
- written informed consent
Exclusion
- pregestational diabetes (type 1 or type 2)
- include known known skin adhesive allergy which would prevent subject from wearing a CGM,
- history of bariatric surgery or other surgeries that induce malabsorption
- long-term use (\>2 weeks) of systemic steroids during the testing interval
- inability or refusal to comply with protocol
Key Trial Info
Start Date :
February 6 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 16 2024
Estimated Enrollment :
39 Patients enrolled
Trial Details
Trial ID
NCT06057805
Start Date
February 6 2024
End Date
October 16 2024
Last Update
October 18 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Karen Elkind-Hirsch
Baton Rouge, Louisiana, United States, 70817